BALCX | TSUMX | BALCX / TSUMX | |
Total Expense Ratio | 1.31 | 0.71 | 185% |
Annual Report Gross Expense Ratio | 1.31 | 1.17 | 112% |
Fund Existence | 24 years | 6 years | - |
Gain YTD | 9.274 | 13.472 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 256B | 96.6M | 265,010% |
Annual Yield % from dividends | 1.18 | 2.09 | 56% |
Returns for 1 year | 7.16 | 11.99 | 60% |
Returns for 3 years | 27.12 | 34.52 | 79% |
Returns for 5 years | 33.87 | 33.73 | 100% |
Returns for 10 years | 59.19 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LHCVX | 19.44 | 0.12 | +0.62% |
Lord Abbett Health Care R6 | |||
MCSSX | 39.37 | -0.09 | -0.23% |
NYLI WMC Enduring Capital Investor Class | |||
SLYCX | 16.04 | -0.04 | -0.25% |
SEI Large Cap Y (SIMT) | |||
ITHRX | 52.71 | -0.14 | -0.26% |
Hartford Capital Appreciation R3 | |||
VYSVX | 20.90 | -0.22 | -1.04% |
Vericimetry US Small Cap Value |